Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
J Clin Transl Hepatol ; 11(3): 614-625, 2023 Jun 28.
Article in English | MEDLINE | ID: mdl-36969901

ABSTRACT

Background and Aims: Topoisomerase I (TOP1) participates the repair of DNA double-strand breaks (DSBs) upon radiation therapy (RT). RNF144A mediates ubiquitination of catalytic subunit of DNA protein kinase (DNA-PKcs), a critical factor in DSB repair. This study aimed to investigate the natural killer (NK) cell-mediated radiosensitization with TOP1 inhibition and the mechanism by DNA-PKcs/RNF144A. Methods: In vitro synergism with TOP1i or cocultured NK cells and RT were evaluated in human hepatocellular carcinoma (HCC) cell lines (Huh7/PLC5) by clonogenic survivals. Orthotopic xenografts were treated with Lipotecan and/or RT. Protein expression was analyzed by western blotting, immunoprecipitation, subcellular fractionation, and confocal microscopy. Results: Lipotecan/RT had a superior synergistic effect to RT on HCC cells. Combined RT/Lipotecan reduced the xenograft size by 7-fold than RT (p<0.05). Lipotecan caused more radiation-induced DNA damage and DNA-PKcs signaling. The expression of major histocompatibility complex class I-related chain A and B (MICA/B) on tumor cells is associated with the sensitivity to NK cell-mediated lysis. Cocultured NK and HCC cells with Lipotecan radiosensitized HCC cells/tissues with the expression of MICA/B. RNF144A increased more in Huh7 cells with combined RT/TOP1i, and reduced the prosurvival function of DNA-PKcs. The effect was reversed by inhibiting the ubiquitin/proteasome system. In comparison, RNF144A decreased through nuclear translocation with the cumulated DNA-PKcs and radio-resistance of PLC5 cells. Conclusions: TOP1i reinforces NK cell-activated anti-HCC effect of RT through RNF144A mediated DNA-PKcs ubiquitination. RNF144A provides a reason for differentiating radiosensitization effect between HCC cells.

2.
Ying Yong Sheng Tai Xue Bao ; 31(4): 1333-1340, 2020 Apr.
Article in Chinese | MEDLINE | ID: mdl-32530209

ABSTRACT

The application of Water-Sediment Regulation Project provides abundant freshwater for the Yellow River Delta, changes water and sediment condition, as well as brings lots of exogenous substances. Using orthogonal test with three factors and four levels, we examined the effects of water condition, sediment burial depth and exogenous nitrogen input on the growth of wetland plant, Suaeda salsa. The results showed that sediment burial had great effect on protein content and SOD activity. Nitrogen input had great effect on POD activity. CAT activity was not affected by sediment burial, nitrogen input and water depth. The water depth manipulation had significant effect on leaf, stem and total dry weight. With the increases of water depth, leaf, stem and total dry weight showed a decreasing trend, with the maximum values (25.70, 40.86, 69.73 g) at the 2 cm water depth. There was no effect of nitrogen input and sediment burial on dry weight. The results of range analysis showed that the effect of water depth on leaf, stem, root and total dry weight was great, and followed by nitrogen input and sediment burial, with an optimal combination of 2 cm water depth +12 cm sediment burial + 9 g·m-2 nitrogen input. These findings suggested that water condition played a decisive role in affecting the growth of S. salsa. Consequently, more attention should be paid to the control of water depth in the process of water and sediment regulation.


Subject(s)
Chenopodiaceae , Wetlands , China , Nitrogen , Rivers , Water
3.
Huan Jing Ke Xue ; 39(8): 3910-3916, 2018 Aug 08.
Article in Chinese | MEDLINE | ID: mdl-29998701

ABSTRACT

The Yellow River Delta has been facing the threat of functional degradation during the recent years. The Water-Sediment Regulation Project not only supplements abundant freshwater, but also alters the sediment burial and heavy metal levels, which affects vegetation growth. Thus, we selected the pioneer species Suaeda salsa, to study the effects of different sediment burial depths (0, 3, 6, 12 cm) and exogenous Cd inputs (0, 0.5, 1.0, 1.5 mg·kg-1) on biomass allocation and activities of antioxidative enzymes in the coastal wetlands of the Yellow River delta. The results showed that a shallow or moderate burial depth had a stimulatory effect on chlorophyll content, while an excessive burial depth inhibited the growth of Suaeda salsa and chlorophyll content. With increasing Cd input, chlorophyll content and dry mass decreased. At a lower Cd input and moderate burial depth, activities of CAT and SOD increased, and at high levels, SOD activities decreased, while activities of CAT at a 12 cm burial depth and 1.0 mg·kg-1, 1.5 mg·kg-1 Cd input were higher than those for the control (62.66% and 58.56%). CAT activities reached high values (15.76 U·mg-1) at a high Cd input (1.5 mg·kg-1) and burial depth (12 cm). Analysis of variance showed that Cd input had a significant effect on protein content, and CAT and SOD activities, and sediment burial depth had a significant effect on the protein content and SOD activities. Interaction between Cd input and sediment burial depth had a significant effect on CAT and SOD activities (P<0.05). These results demonstrated that sediment burial depth and Cd input had a great influence on the growth of Suaeda salsa, and to some extent, Suaeda salsa could change its biomass allocation and antioxidative enzyme activities to adapt to severe environments.


Subject(s)
Cadmium/chemistry , Chenopodiaceae/enzymology , Wetlands , Antioxidants/metabolism , Biomass , Catalase/metabolism , China , Geologic Sediments , Rivers , Superoxide Dismutase/metabolism
4.
Cancer Cell ; 29(4): 523-535, 2016 Apr 11.
Article in English | MEDLINE | ID: mdl-26996309

ABSTRACT

Akt is frequently hyperactivated in human cancers and is targeted for cancer therapy. However, the physiological consequences of systemic Akt isoform inhibition were not fully explored. We showed that while combined Akt1 and Akt3 deletion in adult mice is tolerated, combined Akt1 and Akt2 deletion induced rapid mortality. Akt2(-/-) mice survived hepatic Akt1 deletion but all developed spontaneous hepatocellular carcinoma (HCC), which is associated with FoxO-dependent liver injury and inflammation. The gene expression signature of HCC-bearing livers is similar to aggressive human HCC. Consistently, neither Akt1(-/-) nor Akt2(-/-) mice are resistant to diethylnitrosamine-induced hepatocarcinogenesis, and Akt2(-/-) mice display a high incidence of lung metastasis. Thus, in contrast to other cancers, hepatic Akt inhibition induces liver injury that could promote HCC.


Subject(s)
Liver Neoplasms, Experimental/genetics , Proto-Oncogene Proteins c-akt/deficiency , Age Factors , Animals , Blood Glucose/analysis , Energy Metabolism/genetics , Fatty Acids/metabolism , Female , Forkhead Box Protein O1 , Forkhead Transcription Factors/physiology , Growth Disorders/genetics , Hepatitis/genetics , Hypoglycemia/genetics , Insulin/blood , Insulin Resistance , Interleukin-6/blood , Liver Neoplasms, Experimental/chemically induced , Lung Neoplasms/secondary , Male , Mice , Mice, Knockout , Promoter Regions, Genetic/drug effects , Protein Isoforms/physiology , Proto-Oncogene Proteins c-akt/genetics , Proto-Oncogene Proteins c-akt/physiology , Recombinant Fusion Proteins/metabolism
5.
Cell Rep ; 12(4): 610-21, 2015 Jul 28.
Article in English | MEDLINE | ID: mdl-26190111

ABSTRACT

Akt is frequently activated in human cancers. However, it is unknown whether systemic inhibition of a single Akt isoform could regress cancer progression in cancers that are not driven by Akt activation. We systemically deleted Akt1 after tumor onset in p53(-/-) mice, which develop tumors independently of Akt activation. Systemic Akt1 deletion regresses thymic lymphoma in p53(-/-) mice emulating p53 restoration. Furthermore, pharmacological inhibition of Akt selectively kills thymic lymphoma cells and not primary thymocytes. Mechanistically, Akt1 inhibition in p53(-/-) thymic lymphoma inhibits Skp2 expression and induces FasL, which is the primary cause of cell death. Skp2 exerts resistance to cell death by antagonizing the induction of FasL and reducing FAS expression, which is linked to cyclin D1 expression. The results established a paradigm whereby systemic Akt1 inhibition is sufficient to regress tumors that are not driven by Akt activation and a mechanism of cell survival by Skp2.


Subject(s)
Longevity , Lymphoma/metabolism , Proto-Oncogene Proteins c-akt/genetics , Thymocytes/metabolism , Tumor Suppressor Protein p53/genetics , Animals , Apoptosis , Cell Line, Tumor , Fas Ligand Protein/metabolism , Humans , Lymphoma/pathology , Mice , Proto-Oncogene Proteins c-akt/metabolism , S-Phase Kinase-Associated Proteins/genetics , S-Phase Kinase-Associated Proteins/metabolism , Thymocytes/pathology , Tumor Suppressor Protein p53/metabolism
6.
J Biol Chem ; 285(31): 23790-8, 2010 Jul 30.
Article in English | MEDLINE | ID: mdl-20495005

ABSTRACT

Akt is perhaps the most frequently activated oncoprotein in human cancers. Overriding cell cycle checkpoint in combination with the inhibition of apoptosis are two principal requirements for predisposition to cancer. Here we show that the activation of Akt is sufficient to promote these two principal processes, by inhibiting Chk1 activation with concomitant inhibition of apoptosis. These activities of Akt cannot be recapitulated by the knockdown of Chk1 alone or by overexpression of Bcl2. Rather the combination of Chk1 knockdown and Bcl2 overexpression is required to recapitulate Akt activities. Akt was shown to directly phosphorylate Chk1. However, we found that Chk1 mutants in the Akt phosphorylation sites behave like wild-type Chk1 in mediating G2 arrest, suggesting that the phosphorylation of Chk1 by Akt is either dispensable for Chk1 activity or insufficient by itself to exert an effect on Chk1 activity. Here we report a new mechanism by which Akt affects G2 cell cycle arrest. We show that Akt inhibits BRCA1 function that induces G2 cell cycle arrest. Akt prevents the translocation of BRCA1 to DNA damage foci and, thereby, inhibiting the activation of Chk1 following DNA damage.


Subject(s)
BRCA1 Protein/metabolism , Gene Expression Regulation, Enzymologic , Protein Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Animals , Cell Line, Tumor , Checkpoint Kinase 1 , DNA Damage , Fibroblasts/metabolism , G2 Phase , Humans , Mutation , Phosphorylation , RNA Interference , Rats
7.
J Biol Chem ; 279(1): 13-8, 2004 Jan 02.
Article in English | MEDLINE | ID: mdl-14578361

ABSTRACT

Cellular FLICE (FADD-like interleukin-1-beta-converting enzyme)-inhibitory protein (c-FLIP) inhibits death receptor-induced apoptosis by binding to FADD (Fas-associated death domain protein) and pro-caspase-8. c-FLIP has also been shown to transmit activation signals and to enhance interleukin (IL)-2 production. However, c-FLIP-mediated T cell activation is difficult to detect in most cells. We found that in DO11.10 T cells, c-FLIP expression led to inhibition of IL-2 production, in contrast to the readily detectable c-FLIP-induced activation in Jurkat cells. A direct comparison revealed that distinct signal pathways were regulated by c-FLIP in Jurkat cells and DO11.10 cells. We investigated whether constitutively activated phosphatidylinositide 3-kinase (PI3K) in Jurkat cells stimulated c-FLIP. Inhibition of PI3K in Jurkat cells abrogated a c-FLIP-mediated increase in IL-2 production. In addition, c-FLIP coordinated with active PI3K for ERK activation. Furthermore, introduction of PTEN back into Jurkat cells eliminated the stimulatory effect of c-FLIP on IL-2 production and ERK activation. Our results suggest that priming with PI3K promotes the coupling of c-FLIP to T cell activation.


Subject(s)
Carrier Proteins/metabolism , Intracellular Signaling Peptides and Proteins , Lymphocyte Activation/immunology , Phosphatidylinositol 3-Kinases/metabolism , T-Lymphocytes/immunology , CASP8 and FADD-Like Apoptosis Regulating Protein , Carrier Proteins/genetics , Carrier Proteins/immunology , Cell Line , Enzyme Activation , Humans , Interleukin-2/antagonists & inhibitors , Interleukin-2/biosynthesis , Jurkat Cells , MAP Kinase Signaling System/physiology , Mitogen-Activated Protein Kinases/metabolism , PTEN Phosphohydrolase , Phosphoric Monoester Hydrolases/genetics , Phosphoric Monoester Hydrolases/metabolism , Recombinant Proteins/metabolism , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...